AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 JUN 3 - (NewsRx.com & NewsRx.net) -- Quest Diagnostics Incorporated (DGX) has developed and is now offering a gene-based blood test to detect genetic mutations associated with congenital adrenal hyperplasia (CAH).
The new test, which is available to physicians nationwide, detects 90-95% of genetic mutations associated with congenital adrenal hyperplasia. This test can be of value to individuals with the disease as well as families with a history of CAH.
In addition, obstetricians can use the gene-based test during a patient's pregnancy to guide the use of therapy to prevent malformations in affected female fetuses. Currently, CAH testing is a part of a neo-natal blood screen in the majority of states to identify infants with the severe form of the disease.
CAH, a condition that causes females to accumulate male sex hormones, may be inherited by both males and females.
The non-classical mild ...
Source: HighBeam Research, Gene-based test detects mutations linked with congenital adrenal...